Genetics and Genomic Studies in Scleroderma (Systemic Sclerosis)

Division of Rheumatology, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin, MSB 5.270, Houston, TX 77030, USA.
Rheumatic Disease Clinics of North America (Impact Factor: 2.69). 03/2008; 34(1):17-40; v. DOI: 10.1016/j.rdc.2007.10.001
Source: PubMed


It currently is believed that scleroderma is a complex polygenic disease that occurs in genetically predisposed individuals who have encountered specific environment exposures and/or other stochastic factors. The nature of these genetic determinants and how they interact with environmental factors are areas of active investigation. This article discusses the evidence that supports a strong genetic link to scleroderma. These studies implicate potential pathogenetic mechanisms involved in scleroderma, which, it is hoped, may translate into clinical utility, including determination of disease risk, diagnosis, prognosis, and novel therapeutics.

Full-text preview

Available from:
Show more